Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Үндсэн зохиолчид: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
American Society for Clinical Investigation
2019
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Diagnostic use of autoantibodies in myasthenia gravis.
-н: Leite, M, зэрэг
Хэвлэсэн: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
-н: Miriam L. Fichtner, зэрэг
Хэвлэсэн: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
-н: Gomez, A, зэрэг
Хэвлэсэн: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
-н: Miriam L Fichtner, зэрэг
Хэвлэсэн: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
-н: Miriam L. Fichtner, зэрэг
Хэвлэсэн: (2022-01-01)